Digital panel discussion about transfer from academic research into business in the life sciences. 🧬🧫🧑🔬 Join and gain expert insights!💡
Our #TechnologyTransfer working group is offering a one-hour digital discussion on February 15th. From 1:30 to 3:00 pm we discuss the topic of "Valuation of Academic Spin-outs in the Life Sciences". Participation is free of charge (see link below). Academic spin-outs play a pivotal role in translating groundbreaking research into innovative products and therapies. However, valuing these emerging ventures presents unique challenges due to their inherent complexities, early-stage development, and intellectual property considerations. In this webinar, experienced practitioners from Venture Capital, Business Angels and academic Technology Transfer Organisations will share their experience, discuss their approaches and shed light on the intricacies of valuing these pioneering startups. Moderation Birgit Kerber, Head Innovation and Translation, EMBL-EM Thomas Hanke, EVP, Head of Academic Partnerships at Evotec Speaker Anke Cassing, High-Tech Gründerfonds Management Dr. Dmitrij Hristodorov, Forbion Ulrich Mahr, Max-Planck Innovation Stefanie Possekel, Ascenion https://lnkd.in/dj_8mM3M